Wednesday, 18 January 2023
Researchers at the 糖心原创 have developed a digital toolkit designed to support employees with self-management of chronic pain at work. The aim is to improve their ability to work and be productive at work.
Professor Holly Blake, Professor of Behavioural Medicine at the School of Health Sciences at the 糖心原创, developed the Pain at Work (PAW) toolkit in partnership with people living with chronic or persistent pain, employers, healthcare professionals and the pain charity, Burning Nights.
This trial is one of six new research projects announced today (18 January 2023), which has been awarded funding from The Nuffield Foundation and Versus Arthritis. The two organisations have committed £1.94 million of funding to improve the well-being and working lives of people with musculoskeletal (MSK) conditions.
We hope that, by using the toolkit, it will help employers retain people with chronic pain in the active workforce, improve the quality of people鈥檚 lives and reduce social inequality.
The PAW toolkit is an open access, free, online resource, for people working in any role, organisation and sector. It includes individual stories from those living with chronic or persistent pain alongside content covering topics such as understanding chronic or persistent pain, returning to work, reasonable adjustments in the workplace, physical and psychological self-management techniques, and employment rights.
Speaking about the importance of a workplace trial, Professor Blake said: “More than 20 million adults in the UK are living with chronic pain and this figure is likely to rise. Chronic pain impacts on people’s physical and mental wellbeing, as well as their ability to work or be productive at work. Sickness, absence, and reduced productivity costs the UK economy around £73 billion per year.
“Access to support to help people manage their pain at work varies. Many people living with painful conditions don’t get the support they need either from clinical services or their employer. We’ve developed a digital toolkit that aims to build people’s knowledge, skills and confidence to support and effectively self-manage a painful condition at work.
“The research will explore the practicality, usefulness and acceptability of the Pain at Work toolkit for employees and managers in different workplace settings. We hope that, by using the toolkit, it will help employers retain people with chronic pain in the active workforce, improve the quality of people’s lives and reduce social inequality.”
Dr Catherine Dennison, lead for the Oliver Bird Fund Programme at the Nuffield Foundation, added: “These six research projects align around issues that can make it very challenging for people with MSK conditions to enjoy full and rewarding lives.
“We are really delighted to be partnering again with Versus Arthritis to fund research that aims to address some of these barriers and find new and better ways to support people with MSK conditions.”
Dr Sarah Rudkin, Head of Research Strategy and Growth at Versus Arthritis added: “Many of the issues linked to living with an MSK condition such as the inability to work, strain on mental health, deprivation, or social exclusion, cannot be addressed by medical treatments alone.
“More research is needed to understand the social, economic, and psychological reasons why people with MSK conditions are more at risk of these issues and, crucially, what can be done to prevent this, so that we can better support people to live well with their condition.
“These six projects – that will ensure those with lived experience are involved at every stage – will advance our understanding in all these areas and make a real difference for people living with conditions like arthritis.”
For more information visit:
Story credits
For further information, please email Holly Blake, Professor of Behavioural Medicine holly.blake@nottingham.ac.uk
Adam Mallaby - Media Relations Manager for the Faculty of Medicine and Health Sciences (Maternity Cover)
Email: adam.mallaby@nottingham.ac.uk
Phone: 0115 748 5719
Location:
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.